iRhythm Technologies Inc header image

iRhythm Technologies Inc

IRTC

Equity

ISIN null / Valor 34117792

NASDAQ (2025-11-21)
USD 177.82+4.78%

iRhythm Technologies Inc
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

iRhythm Technologies Inc is a prominent digital healthcare company known for its innovative solutions in disease detection, prediction, and prevention. The company utilizes wearable biosensors and cloud-based data analytics, along with proprietary algorithms, to analyze data from millions of heartbeats and provide clinically actionable information. One of its key offerings is the Zio service, which is a comprehensive ambulatory cardiac monitoring solution featuring single-use monitors that are patient-friendly and supported by clinical evidence.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (08.10.2025):

iRhythm Technologies Inc reported its financial results for the fourth quarter of 2024, showcasing a robust 24% increase in revenue, significant improvements in gross margin, and a substantial reduction in net loss compared to the same period in the previous year.

Revenue Growth

Revenue for Q4 2024 reached $164.3 million, marking a 24.0% increase from $132.5 million in Q4 2023. This growth was primarily driven by higher volumes of Zio Services due to increased demand across all customer channels.

Improved Gross Margin

The gross margin surged to 70.0% in Q4 2024, up from 66.0% in Q4 2023. This improvement reflects operational efficiencies that reduced costs per unit while serving a higher volume of patients.

Reduced Net Loss

Net loss for the fourth quarter narrowed to $1.3 million, a significant improvement from a net loss of $38.7 million in Q4 2023. This improvement was driven by increased revenue and reduced operating expenses.

Adjusted EBITDA Enhancement

Adjusted EBITDA for Q4 2024 was $19.3 million, representing a $16.9 million improvement compared to Q4 2023. This highlights the company's progress in achieving operational profitability.

Strong Cash Position

As of December 31, 2024, iRhythm Technologies Inc maintained a healthy cash, cash equivalents, and marketable securities balance of $535.6 million, reflecting a $13.6 million increase from September 30, 2024.

Summarized from source with an LLMView Source

Key figures

141%1Y
75.6%3Y
-20.8%5Y

Performance

47.1%1Y
51.0%3Y
69.5%5Y

Volatility

Market cap

5729 M

Market cap (USD)

Daily traded volume (Shares)

510,827

Daily traded volume (Shares)

1 day high/low

88.7 / 86.19

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
5.00
Thomas Jarrett
United Kingdom, 08 Nov 2025
star star star star star
Sick

EQUITIES OF THE SAME SECTOR

Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 85.13
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 342.20